Comparison of tocilizumab as monotherapy or with add-on disease-modifying antirheumatic drugs in patients with rheumatoid arthritis and inadequate responses to previous treatments: an open-label study close to clinical practice

V.P. Bykerk; A.J.K. Ostor; J. Alvaro-Gracia; K. Pavelka; J.A.R. Ivorra; W. Graninger; W. Bensen; M.T. Nurmohamed; A. Krause; C. Bernasconi; M. Aassi; J Sibilia

doi:https://doi.org/10.1007/s10067-014-2857-y

Comparison of tocilizumab as monotherapy or with add-on disease-modifying antirheumatic drugs in patients with rheumatoid arthritis and inadequate responses to previous treatments: an open-label study close to clinical practice

V.P. Bykerk, A.J.K. Ostor, J. Alvaro-Gracia, K. Pavelka, J.A.R. Ivorra, W. Graninger, W. Bensen, M.T. Nurmohamed, A. Krause, C. Bernasconi, M. Aassi, J Sibilia

Rheumatology (VUmc)

Research output: Contribution to journal › Article › Academic › peer-review

31 Citations (Scopus)

Original language	Undefined/Unknown
Pages (from-to)	563-571
Journal	Clinical Rheumatology
Volume	34
Issue number	3
DOIs	https://doi.org/10.1007/s10067-014-2857-y
Publication status	Published - 2015

Access to Document

https://doi.org/10.1007/s10067-014-2857-y

Cite this

Bykerk, V. P., Ostor, A. J. K., Alvaro-Gracia, J., Pavelka, K., Ivorra, J. A. R., Graninger, W., Bensen, W., Nurmohamed, M. T., Krause, A., Bernasconi, C., Aassi, M., & Sibilia, J. (2015). Comparison of tocilizumab as monotherapy or with add-on disease-modifying antirheumatic drugs in patients with rheumatoid arthritis and inadequate responses to previous treatments: an open-label study close to clinical practice. Clinical Rheumatology, 34(3), 563-571. https://doi.org/10.1007/s10067-014-2857-y

@article{4683d53d7afc4215bfaedc73aa6f653b,

title = "Comparison of tocilizumab as monotherapy or with add-on disease-modifying antirheumatic drugs in patients with rheumatoid arthritis and inadequate responses to previous treatments: an open-label study close to clinical practice",

author = "V.P. Bykerk and A.J.K. Ostor and J. Alvaro-Gracia and K. Pavelka and J.A.R. Ivorra and W. Graninger and W. Bensen and M.T. Nurmohamed and A. Krause and C. Bernasconi and M. Aassi and J Sibilia",

year = "2015",

doi = "https://doi.org/10.1007/s10067-014-2857-y",

language = "Undefined/Unknown",

volume = "34",

pages = "563--571",

journal = "Clinical Rheumatology",

issn = "0770-3198",

publisher = "Springer London",

number = "3",

}

Bykerk, VP, Ostor, AJK, Alvaro-Gracia, J, Pavelka, K, Ivorra, JAR, Graninger, W, Bensen, W, Nurmohamed, MT, Krause, A, Bernasconi, C, Aassi, M & Sibilia, J 2015, 'Comparison of tocilizumab as monotherapy or with add-on disease-modifying antirheumatic drugs in patients with rheumatoid arthritis and inadequate responses to previous treatments: an open-label study close to clinical practice', Clinical Rheumatology, vol. 34, no. 3, pp. 563-571. https://doi.org/10.1007/s10067-014-2857-y

Comparison of tocilizumab as monotherapy or with add-on disease-modifying antirheumatic drugs in patients with rheumatoid arthritis and inadequate responses to previous treatments: an open-label study close to clinical practice. / Bykerk, V.P.; Ostor, A.J.K.; Alvaro-Gracia, J. et al.
In: Clinical Rheumatology, Vol. 34, No. 3, 2015, p. 563-571.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Comparison of tocilizumab as monotherapy or with add-on disease-modifying antirheumatic drugs in patients with rheumatoid arthritis and inadequate responses to previous treatments: an open-label study close to clinical practice

AU - Bykerk, V.P.

AU - Ostor, A.J.K.

AU - Alvaro-Gracia, J.

AU - Pavelka, K.

AU - Ivorra, J.A.R.

AU - Graninger, W.

AU - Bensen, W.

AU - Nurmohamed, M.T.

AU - Krause, A.

AU - Bernasconi, C.

AU - Aassi, M.

AU - Sibilia, J

PY - 2015

Y1 - 2015

U2 - https://doi.org/10.1007/s10067-014-2857-y

DO - https://doi.org/10.1007/s10067-014-2857-y

M3 - Article

C2 - 25604316

SN - 0770-3198

VL - 34

SP - 563

EP - 571

JO - Clinical Rheumatology

JF - Clinical Rheumatology

IS - 3

ER -

Bykerk VP, Ostor AJK, Alvaro-Gracia J, Pavelka K, Ivorra JAR, Graninger W et al. Comparison of tocilizumab as monotherapy or with add-on disease-modifying antirheumatic drugs in patients with rheumatoid arthritis and inadequate responses to previous treatments: an open-label study close to clinical practice. Clinical Rheumatology. 2015;34(3):563-571. doi: https://doi.org/10.1007/s10067-014-2857-y